SGMT Overview
Upcoming Projects (SGMT)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (SGMT)
-
A second look: Discussing the potential of Sagimet's denifanstat in Biopsy-Confirmed F2/F3 NASH with a focus on the Phase 2b FASCINATE-2 trial
Ticker: SGMT
Executed On: Mar 08, 2024 at 01:00 PM EST -
Discussing the potential of Sagimet's denifanstat in Biopsy-Confirmed F2/F3 NASH with a focus on the Phase 2b FASCINATE-2 trial
Ticker: SGMT
Executed On: Jan 29, 2024 at 04:00 PM EST -
A Third View: Looking into Sagimet's potential drug candidate denifanstat for the treatment of Nonalcoholic steatohepatitis (NASH)
Tickers: SGMT, NVO
Executed On: Jul 26, 2023 at 10:00 AM EDT -
A Second View: Looking into Sagimet's potential drug candidate denifanstat for the treatment of Nonalcoholic steatohepatitis (NASH)
Ticker: SGMT
Executed On: Jul 14, 2023 at 03:00 PM EDT -
Looking into Sagimet's potential drug candidate denifanstat for the treatment of Nonalcoholic steatohepatitis (NASH)
Ticker: SGMT
Executed On: Jul 14, 2023 at 08:00 AM EDT
Upcoming & Overdue Catalysts (SGMT)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (SGMT)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
